Cathepsin L Fluorogenic Probe for Selective Low-Background Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing fluorogenic probes for cathepsin L activity, such as Z-FR-AMC, suffer from off-target detection by cathepsins B and C, leading to high background emission and reduced sensitivity due to their activation by these enzymes, complicating assay results.

Innovation Solution

Development of a fluorogenic probe, CTLAP, with enhanced selectivity for cathepsin L over other cathepsins, characterized by a 6- to 10-fold selectivity and 24-fold increase in emission intensity within 10 minutes of incubation, featuring a chemical structure optimized for cathepsin L recognition and minimal background intensity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If Z-FR-AMC probe is used for cathepsin L detection, then detection capability is achieved, but off-target detection by cathepsins B and C occurs leading to high background emission

Engineering Contradiction:
Improvedetection specificityVSAvoidbackground emission
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent modifies the probe structure at specific positions (P1, P2, P3 residues) to create localized differences in enzyme-substrate recognition. The use of specific amino acid residues (e.g., P1: Arg or Lys, P2: Phe or Tyr, P3: Cbz-protected amino acid) provides selective binding to cathepsin L while reducing off-target binding to cathepsins B and C, thereby improving detection specificity without increasing background emission.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent systematically varies chemical parameters of the probe including different fluorophores (AMC, 7-amino-4-methylcoumarin), different amino acid residues at key positions, and different linkers to optimize the balance between detection sensitivity and selectivity. This parameter optimization results in probes that maintain low background emission while achieving high detection specificity for cathepsin L.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If fluorogenic probe structure is optimized for selectivity, then off-target detection is reduced, but detection sensitivity may be compromised

Engineering Contradiction:
Improvedetection specificityVSAvoiddetection sensitivity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent creates composite probe molecules combining multiple functional elements: a fluorophore (AMC), a peptide sequence with specific amino acid residues at P1, P2, P3 positions, and optional linker groups. This composite structure allows simultaneous optimization of selectivity (through specific residue composition) and sensitivity (through fluorophore selection and molecular architecture), achieving both high detection specificity and reliability.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent designs probes that undergo conformational or chemical changes upon enzyme binding and cleavage. The fluorogenic response is dynamically generated when the enzyme cleaves the peptide bond, releasing the fluorophore from the quenched state. This dynamic mechanism ensures that selectivity is maintained during binding while sensitivity is maximized during the detection phase.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

CTLAP provides improved sensitivity and specificity in detecting cathepsin L activity by minimizing off-target signals from competing cathepsins, enabling more accurate and sensitive assays.

Implementation Method 1

CTLAP, a fluorogenic probe exhibiting both selectivity for CTL over other cathepsins (6- to 10-fold), and a low background intensity compared to a commercial standard probe (sc-3136), providing a 24-fold increase in emission intensity within 10 min of incubation with CTL

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12384767B2Probe for detection of cathepsin activity
Publication Date: 2025.08.12 UNIV OF FLORIDA RESEARCH FOUNDATION INC
  • US12384767B2 patent drawing
  • US12384767B2 patent drawing
  • US12384767B2 patent drawing

AI summary

In this vein, we present CTLAP, a fluorogenic probe that is rapidly activated by CTL and displays good selectivity over CTB and CTV, the closest competing analytes for CTL activity probes. CTLAP exhibits intrinsically low background fluorescence, which we attribute to the notably low quantum yield measured for the probe. CTLAP demonstrates markedly higher turn-on ratios (24-fold) and moderately improved enzyme selectivity (6- to 10-fold) when compared to Z-FR-AMC (10-fold turn-on ratio, 6- to 7-fold selectivity), a commercially available CTL-selective probe commonly used to detect CTL activity in mixed samples. Optimum selectivity for CTL is achieved within 10 min of incubation with the enzyme, suggesting that CTLAP is amenable for rapid detection of CTL, even in the presence of competing cathepsins.